These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 621672

  • 21. Proceedings: Excitatory and inhibitory monosynaptic actions mediated by a serotonin containing neurone in Aplysia californica.
    Gerschfeld HM, Paupardin-Tritsch D.
    J Physiol; 1973 Oct; 234(2):28P-29P. PubMed ID: 4358350
    [No Abstract] [Full Text] [Related]

  • 22. Some observations on the behavioural effects of hallucinogenic drugs on rats: potentiation by two drugs affecting monoamine metabolism.
    Tonge SR, Leonard BE.
    Arch Int Pharmacodyn Ther; 1972 Jan; 195(1):168-76. PubMed ID: 5010826
    [No Abstract] [Full Text] [Related]

  • 23. An economical screen for phenethylamine-type hallucinogens: mouse ear scratching.
    Yim GK, Prah TE, Pfister WR, Nichols DE.
    Commun Psychopharmacol; 1979 Jan; 3(3):173-8. PubMed ID: 574070
    [No Abstract] [Full Text] [Related]

  • 24. The pharmacology of hallucinogens.
    Brawley P, Duffield JC.
    Pharmacol Rev; 1972 Mar; 24(1):31-66. PubMed ID: 4626282
    [No Abstract] [Full Text] [Related]

  • 25. 1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists.
    McLean TH, Parrish JC, Braden MR, Marona-Lewicka D, Gallardo-Godoy A, Nichols DE.
    J Med Chem; 2006 Sep 21; 49(19):5794-803. PubMed ID: 16970404
    [Abstract] [Full Text] [Related]

  • 26. The use of drug discrimination procedures to characterize hallucinogenic drug actions.
    Appel JB, Cunningham KA.
    Psychopharmacol Bull; 1986 Sep 21; 22(3):959-67. PubMed ID: 3797596
    [No Abstract] [Full Text] [Related]

  • 27. Actions of serotonin and related substances on single neurons in the brain.
    Bradley PB, Briggs I.
    Adv Biochem Psychopharmacol; 1974 Sep 21; 10():159-66. PubMed ID: 4527120
    [No Abstract] [Full Text] [Related]

  • 28. In vivo evidence of partial agonist activity exerted by purported 5-hydroxytryptamine antagonists.
    Colpaert FC, Niemegeers CJ, Janssen PA.
    Eur J Pharmacol; 1979 Oct 15; 58(4):505-9. PubMed ID: 510385
    [Abstract] [Full Text] [Related]

  • 29. Behavioral and biochemical evidence for a nonessential 5-HT2A component of the ibogaine-induced discriminative stimulus.
    Helsley S, Fiorella D, Rabin RA, Winter JC.
    Pharmacol Biochem Behav; 1998 Feb 15; 59(2):419-25. PubMed ID: 9476990
    [Abstract] [Full Text] [Related]

  • 30. LSD as a discriminative stimulus: role of dorsal raphe nucleus.
    Minnema D, Krynock G, Young R, Glennon R, Rosecrans J.
    Subst Alcohol Actions Misuse; 1980 Feb 15; 1(1):29-34. PubMed ID: 7323940
    [No Abstract] [Full Text] [Related]

  • 31. LSD and phenethylamine hallucinogens: new structural analogy and implications for receptor geometry.
    Nichols DE, Pfister WR, Yim GK.
    Life Sci; 1978 Jun 26; 22(24):2165-70. PubMed ID: 672453
    [No Abstract] [Full Text] [Related]

  • 32. Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity.
    Monte AP, Marona-Lewicka D, Lewis MM, Mailman RB, Wainscott DB, Nelson DL, Nichols DE.
    J Med Chem; 1998 Jun 04; 41(12):2134-45. PubMed ID: 9622555
    [Abstract] [Full Text] [Related]

  • 33. Drug-induced discrimination: a description of the paradigm and a review of its specific application to the study of hallucinogenic agents.
    Glennon RA, Rosecrans JA, Young R.
    Med Res Rev; 1983 Jun 04; 3(3):289-340. PubMed ID: 6350763
    [No Abstract] [Full Text] [Related]

  • 34. Molecular modeling of the interaction of LSD and other hallucinogens with 5-HT2 receptors.
    Westkaemper RB, Glennon RA.
    NIDA Res Monogr; 1994 Jun 04; 146():263-83. PubMed ID: 8742803
    [No Abstract] [Full Text] [Related]

  • 35. LSD, 5-HT (serotonin), and the evolution of a behavioral assay.
    Appel JB, West WB, Buggy J.
    Neurosci Biobehav Rev; 2004 Jan 04; 27(8):693-701. PubMed ID: 15019419
    [Abstract] [Full Text] [Related]

  • 36. A characteristic effect of hallucinogens on investigatory responding in rats.
    Geyer MA, Light RK, Rose GJ, Petersen LR, Horwitt DD, Adams LM, Hawkins RL.
    Psychopharmacology (Berl); 1979 Sep 04; 65(1):35-40. PubMed ID: 116288
    [Abstract] [Full Text] [Related]

  • 37. Structure-activity-relationships of certain hallucinogenic substances based on brain levels.
    Vogel WH, Evans BD.
    Life Sci; 1977 May 15; 20(10):1629-35. PubMed ID: 69244
    [No Abstract] [Full Text] [Related]

  • 38. Structural correlation between apomorphine and LSD: involvement of dopamine as well as serotonin in the actions of hallucinogens.
    Nichols DE.
    J Theor Biol; 1976 Jun 15; 59(1):167-77. PubMed ID: 7711
    [No Abstract] [Full Text] [Related]

  • 39. An electrographic study of d-lysergic acid diethylamide and nine congeners.
    Schweigerdt AK, Stewart AH, Himwich HE.
    J Pharmacol Exp Ther; 1966 Mar 15; 151(3):353-9. PubMed ID: 5938474
    [No Abstract] [Full Text] [Related]

  • 40. [Differences in the pharmacological effect of hallucinogenic and von-hallucinogenic lysergic acid derivatives (LSD 25, deseril, lysenyl, mesenyl)].
    Votava Z, Podvalová I, Vojtĕchovský M.
    Arzneimittelforschung; 1966 Feb 15; 16(2):220-2. PubMed ID: 6014083
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.